mimosa: monalizumab and trastuzumab in her2 breast cancer
Published 3 years ago • 212 plays • Length 2:06Download video MP4
Download video MP3
Similar videos
-
1:11
the mimosa trial and a novel prognostic factor in breast cancer
-
4:29
pertuzumab, trastuzumab and cyclophosphamide in older patients with her2 breast cancer
-
1:12
trastuzumab deruxtecan in metastatic her2 breast cancer
-
1:29
tuxedo-1: trastuzumab deruxtecan for the treatment of her2-positive breast cancer brain metastases
-
2:00
tulip: trastuzumab duocarmazine improved pfs in pre-treated her2 breast cancer
-
2:49
neratinib, trastuzumab fulvestrant for her2-mutant, hr , metastatic breast cancer
-
1:12
her2climb-04: tucatinib trastuzumab deruxtecan in her2 breast cancer
-
5:55
decision-making in metastatic her2 breast cancer
-
3:51
study comparing margetuximab combinations to trastuzumab combinations in her2-positive breast cancer
-
1:35
advances in novel adcs for her2-expressing breast cancer
-
1:17
clinical outcomes in women with metastatic her2-low breast cancer in the real world
-
4:16
adjuvant treatment for stage i her2 breast cancer
-
1:56
persephone: 6 vs. 12-month adjuvant trastuzumab in early breast cancer
-
2:09
the evolution of her2 targeting in metastatic breast breast cancer
-
0:31
remaining questions regarding her2-low breast cancer
-
2:08
destiny-breast07: t-dxd /- pertuzumab in patients with metastatic her2 breast cancer
-
2:33
her2climb: tucatinib with trastuzumab and capecitabine for her2 breast cancer with brain metastases
-
1:56
apt: adjuvant paclitaxel and trastuzumab for node-negative, her2 breast cancer
-
2:29
mountaineer: tucatinib plus trastuzumab for her2 metastatic colorectal cancer